Company Overview
Company Name
Alnylam Pharmaceuticals
Address
665 Concord Ave, Cambridge, MA, 02138, United States
Website
alnylam.comPhone
617.551.8200Employees
1,001
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company based in Cambridge, MA, with approximately 1,001 employees. The company focuses on developing RNAi therapeutics for the treatment of amyloidosis, hyperoxaluria, and porphyria, leveraging its proprietary delivery platforms and pipeline of clinical-stage programs.
Frequently Asked Questions about Alnylam Pharmaceuticals
Technologies Used
Social Profiles
Key Decision Makers
Vanessa Bahnam Clinical Trial Manager
Nitender Goyal Director Clinical Research
Weiyi Li Clinical Trial Manager
Stephanie S. Clinical Trial Specialist
Terry Maratos-Flier Director Clinical Research
Melanie Keltz Clinical Trial Specialist
Kenasha J. Manager, Clinical Operations
Joseph Barry Associate Director, Data Sciences
Jacob D Martin Clinical Trial Manager
Jeremy Whitley, M.S. Clinical Trial Manager
Sofia Moniz, MBA Clinical Trial Manager
Rose M. Kaplan, MS, RD, LDN Clinical Trial Manager
Laura Doyle Senior Director, Clinical Operations